2025 is set to sizzle in BioPharma. 🔥

Everyone’s talking about #CagriSema from #Novo 23% weight loss but the real game-changer may be Lilly’ Orforglipron.

Why? It could deliver a 3-in-1 win—efficacy, tolerance, and oral delivery. 💊 If it does, Lilly might dominate the space.

Let 2025 begin! 🚀